Skeletal muscle RAS and exercise performance

被引:141
作者
Jones, A
Woods, DR [1 ]
机构
[1] Freeman Rd Hosp, Dept Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] UCL, Rayne Inst, Dept Cardiovasc Genet, London WC1E 6JJ, England
关键词
renin-angiotensin system; muscle; exercise; performance; ACE;
D O I
10.1016/S1357-2725(02)00342-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A local renin-angiotensin system (RAS) may be suggested by evidence of gene expression of RAS components within the tissue as well as physiological responsiveness of this gene expression. This-review will focus on the evidence supporting the existence of the constituent elements of a physiologically functional paracrine muscle RAS. The effect of local skeletal muscle RAS on human exercise performance will be explored via its relation with pharmacological intervention and genetic studies. The most likely configuration of the muscle RAS is a combination of in situ synthesis and uptake from the circulation of RAS components. A reduction in angiotensin-converting enzyme (ACE) activity reverses the decline in physical performance due to peripheral muscle factors in those with congestive heart failure and may halt or slow decline in muscle strength in elderly women. Genetic studies suggest that increased ACE and angiotensin II (Ang II) mediate greater strength gains perhaps via muscle hypertrophy whereas lower ACE levels and reduced bradykinin (BK) degradation mediate enhanced endurance performance perhaps via changes in substrate availability, muscle fibre type and efficiency. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:855 / 866
页数:12
相关论文
共 120 条
  • [1] REGIONAL ANGIOTENSIN-II PRODUCTION IN ESSENTIAL-HYPERTENSION AND RENAL-ARTERY STENOSIS
    ADMIRAAL, PJJ
    DANSER, AHJ
    JONG, MS
    PIETERMAN, H
    DERKX, FHM
    SCHALEKAMP, MADH
    [J]. HYPERTENSION, 1993, 21 (02) : 173 - 184
  • [2] METABOLISM AND PRODUCTION OF ANGIOTENSIN-I IN DIFFERENT VASCULAR BEDS IN SUBJECTS WITH HYPERTENSION
    ADMIRAAL, PJJ
    DERKX, FHM
    DANSER, AHJ
    PIETERMAN, H
    SCHALEKAMP, MADH
    [J]. HYPERTENSION, 1990, 15 (01) : 44 - 55
  • [3] Agerholm-Larsen B, 1999, ATHEROSCLEROSIS, V147, P425
  • [4] Angiotensin II receptors in the human brain
    Allen, AM
    MacGregor, DP
    McKinley, MJ
    Mendelsohn, FAO
    [J]. REGULATORY PEPTIDES, 1999, 79 (01) : 1 - 7
  • [5] BELDENT V, 1993, J BIOL CHEM, V268, P26428
  • [6] Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE Family Study
    Bouchard, C
    Rankinen, T
    Chagnon, YC
    Rice, T
    Pérusse, L
    Gagnon, J
    Borecki, I
    An, P
    Leon, AS
    Skinner, JS
    Wilmore, JH
    Province, M
    Rao, DC
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2000, 88 (02) : 551 - 559
  • [7] BOUSHEL R, 2002, J PHYSL, V1, P691
  • [8] Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism
    Brink, M
    Wellen, J
    Delafontaine, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2509 - 2516
  • [9] Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I
    Brink, M
    Price, SR
    Chrast, J
    Bailey, JL
    Anwar, A
    Mitch, WE
    Delafontaine, P
    [J]. ENDOCRINOLOGY, 2001, 142 (04) : 1489 - 1496
  • [10] ACE insertion/deletion genotype affects bradykinin metabolism
    Brown, NJ
    Blais, C
    Gandhi, SK
    Adam, A
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (03) : 373 - 377